Drug Profile
Monoclonal antibody K1
Alternative Names: MAbK1Latest Information Update: 30 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Mesothelioma; Ovarian cancer
Most Recent Events
- 16 Nov 1998 New profile
- 16 Nov 1998 Preclinical development for Mesothelioma in USA (Unknown route)
- 16 Nov 1998 Preclinical development for Ovarian cancer in USA (Unknown route)